Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

Group 1 - Amarin Corporation plc will host a conference call on May 7, 2025, at 8:00 a.m. ET to discuss its first quarter 2025 results [1] - The financial results will be released in the pre-market hours on the same day [1] - The call will include a Q&A session with the management team, including President & CEO Aaron Berg [1] Group 2 - Amarin is an innovative pharmaceutical company focused on cardiovascular disease management, with offices in multiple countries including the United States, Ireland, and Switzerland [3] - The company aims to enhance the scientific understanding of cardiovascular risks that persist beyond traditional therapies [3] - Amarin maintains communication with investors through its website and investor relations section, providing access to various materials and updates [4]